Zoetis granted conditional approval of Dectomax-CA1 for parasitic infection in cattle

PeopleImages

* The US FDA has given [https://seekingalpha.com/pr/20249960-zoetis-receives-conditional-approval-for-dectomax-ca1-injectable-for-the-prevention-and] conditional approval to Dectomax-CA1 (doramectin), an injection to treat New World screwworm myiasis in cattle.
* The infection is caused by larvae of the new world screwworm fly feeding on the flesh of animals.
* Although New World screwworm was eradicated in the US in 1966, Zoetis said [https://www.zoetisus.com/conditions/cattle/new-world-screwworm/] that there is a constant risk of re-introduction.

MORE ON ZOETIS

* Zoetis: Pet Pain Spells Potential Further Gains, But Valuation Suggests A Hold [https://seekingalpha.com/article/4826178-pet-pain-for-investor-gain]
* Zoetis Inc. (ZTS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript [https://seekingalpha.com/article/4820607-zoetis-inc-zts-presents-at-morgan-stanley-23rd-annual-global-healthcare-conference-transcript]
* Zoetis: A Solid Dividend Growth Investment For The Long Haul [https://seekingalpha.com/article/4818252-zoetis-a-solid-dividend-growth-investment-for-the-long-haul]
* Zoetis prices $1.85B senior notes [https://seekingalpha.com/news/4483642-zoetis-prices-185b-senior-notes]
* Zoetis raises 2025 organic operational revenue growth guidance to up to 8% while advancing key franchises [https://seekingalpha.com/news/4478781-zoetis-raises-2025-organic-operational-revenue-growth-guidance-to-up-to-8-percent-while]